Vasudha Pharma Chem Limited Celebrates Dismissal of All Charges by DOJ

Vasudha Pharma Chem Limited Celebrates All Charges Dropped by DOJ

Hyderabad, India - On April 16, 2026, Vasudha Pharma Chem Limited, a premier player in the pharmaceutical bulk drug and intermediate manufacturing sector, announced significant developments regarding its legal standing. The company confirmed that it has successfully entered into a Non-Prosecution Agreement (NPA) with the U.S. Department of Justice (DOJ), leading to the dismissal of all charges previously filed against the firm. This moment comes after Vasudha has steadfastly maintained its innocence throughout the past year.

In a statement reflecting the sentiments of the company, M Ashok Srinivas Raju, Executive Director of Vasudha, expressed, "All of us at Vasudha welcome the resolution of this matter. We are a family of dedicated chemists, chemical engineers, and scientists, and every employee at this company is committed to the responsible and ethical creation of critical pharmaceutical products that help medical patients around the world."

The formal announcement indicated that the DOJ recognized Vasudha’s lack of any prior criminal history and acknowledged the company for its cooperation during the investigation. Anand Mantena, another Executive Director of the company, remarked, “We are very pleased that all charges have been dropped against the company, and that this issue is now resolved. We are back to business as usual and look forward to continuing to serve our customers with the highest degree of care.”

This resolution not only clears Vasudha of all allegations but also cements its reputation as a reputable organization dedicated to compliance and ethical standards. The firm has taken proactive steps by enhancing its compliance program and strengthening internal controls to prevent any potential issues in the future.

Glen McGorty, a former federal prosecutor who played an instrumental role in this legal resolution, stated, "We are pleased that the DOJ agreed to dismiss all charges against Vasudha. The company has acted with dignity and total transparency with the DOJ, and we are proud to have represented them to achieve such a positive result."

Vasudha Pharma Chem Limited has been a steadfast entity in the pharmaceutical industry for over thirty years, serving customers across more than 90 countries, including leading multinational corporations and pharmaceutical firms in regions such as America, Europe, and Latin America. The company's facilities are accredited by the U.S. Food and Drug Administration (FDA) and analogous regulatory bodies in Europe, Japan, and Brazil, showcasing its commitment to quality assurance in manufacturing processes.

Employing over 4,000 personnel, Vasudha has consistently been recognized for its contributions to Corporate Social Responsibility (CSR) efforts in India. The firm is noted for exceeding required social responsibility expenditures, earning a top placement amongst the top 5% of Indian companies, as rated by the Ministry of Corporate Affairs.

In addition to its corporate integrity, Vasudha has pledged 30% of its wealth to charitable causes through its foundation, the VRVV Family Vasudha Foundation. This commitment to philanthropy exemplifies the company’s approach to balancing business success with social responsibility.

As Vasudha Pharma Chem Limited moves forward from this chapter, it continues to underscore its mission of contributing positively to global health through the responsible manufacturing of pharmaceuticals. The dismissal of all charges allows the company to focus entirely on its business operations, bringing peace of mind to its employees, partners, and customers alike. With all legal concerns resolved, the future looks promising for Vasudha as it reaffirms its dedication to ethical practices and high-quality pharmaceutical production.